Better Therapeutics Inc (BTTX)
0.0073
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Better Therapeutics Enterprise Value: 8.055M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 8.055M |
| June 13, 2024 | 8.093M |
| June 12, 2024 | 8.136M |
| June 11, 2024 | 8.140M |
| June 10, 2024 | 8.230M |
| June 07, 2024 | 8.164M |
| June 06, 2024 | 8.202M |
| June 05, 2024 | 8.159M |
| June 04, 2024 | 8.112M |
| June 03, 2024 | 8.171M |
| May 31, 2024 | 8.230M |
| May 30, 2024 | 8.252M |
| May 29, 2024 | 8.183M |
| May 28, 2024 | 8.107M |
| May 24, 2024 | 8.093M |
| May 23, 2024 | 8.183M |
| May 22, 2024 | 8.183M |
| May 21, 2024 | 8.230M |
| May 20, 2024 | 8.278M |
| May 17, 2024 | 8.238M |
| May 16, 2024 | 8.302M |
| May 15, 2024 | 8.230M |
| May 14, 2024 | 8.415M |
| May 13, 2024 | 8.286M |
| May 10, 2024 | 8.226M |
| Date | Value |
|---|---|
| May 09, 2024 | 8.254M |
| May 08, 2024 | 8.138M |
| May 07, 2024 | 8.183M |
| May 06, 2024 | 8.264M |
| May 03, 2024 | 8.183M |
| May 02, 2024 | 8.245M |
| May 01, 2024 | 8.243M |
| April 30, 2024 | 8.325M |
| April 29, 2024 | 8.278M |
| April 26, 2024 | 8.183M |
| April 25, 2024 | 8.136M |
| April 24, 2024 | 8.078M |
| April 23, 2024 | 7.993M |
| April 22, 2024 | 7.998M |
| April 19, 2024 | 8.003M |
| April 18, 2024 | 8.088M |
| April 17, 2024 | 8.136M |
| April 16, 2024 | 8.151M |
| April 15, 2024 | 8.178M |
| April 12, 2024 | 8.273M |
| April 11, 2024 | 8.183M |
| April 10, 2024 | 8.230M |
| April 09, 2024 | 8.121M |
| April 08, 2024 | 8.117M |
| April 05, 2024 | 8.179M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.5407M
Minimum
Apr 29 2022
404.25M
Maximum
Nov 01 2021
36.80M
Average
26.91M
Median
Nov 04 2022
Enterprise Value Benchmarks
| Geron Corp | 2.528B |
| SELLAS Life Sciences Group Inc | 68.22M |
| Immuneering Corp | -26.50M |
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.862M |
| Total Expenses (Quarterly) | 5.341M |
| EPS Diluted (Quarterly) | -0.15 |
| Earnings Yield | -15.75K% |